CA2141060A1 - Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods - Google Patents

Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods

Info

Publication number
CA2141060A1
CA2141060A1 CA002141060A CA2141060A CA2141060A1 CA 2141060 A1 CA2141060 A1 CA 2141060A1 CA 002141060 A CA002141060 A CA 002141060A CA 2141060 A CA2141060 A CA 2141060A CA 2141060 A1 CA2141060 A1 CA 2141060A1
Authority
CA
Canada
Prior art keywords
cyclic gmp
methods
binding
cgb
pde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002141060A
Other languages
French (fr)
Other versions
CA2141060C (en
Inventor
Joseph A. Beavo
Jackie D. Corbin
Kenneth M. Ferguson
Sharron H. Francis
Ann Kadlecek
Kate Loughney
Linda M. Mcallister-Lucas
William K. Sonnenburg
Melissa K. Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Icos Corp
Original Assignee
Joseph A. Beavo
Jackie D. Corbin
Kenneth M. Ferguson
Sharron H. Francis
Ann Kadlecek
Kate Loughney
Linda M. Mcallister-Lucas
William K. Sonnenburg
Melissa K. Thomas
Vanderbilt University
The Board Of Regents Of The University Of Washington
Icos Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22080121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2141060(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Joseph A. Beavo, Jackie D. Corbin, Kenneth M. Ferguson, Sharron H. Francis, Ann Kadlecek, Kate Loughney, Linda M. Mcallister-Lucas, William K. Sonnenburg, Melissa K. Thomas, Vanderbilt University, The Board Of Regents Of The University Of Washington, Icos Corporation filed Critical Joseph A. Beavo
Priority to CA2363537A priority Critical patent/CA2363537C/en
Publication of CA2141060A1 publication Critical patent/CA2141060A1/en
Application granted granted Critical
Publication of CA2141060C publication Critical patent/CA2141060C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Abstract

The present invention provides novel purified and isolated nucleotide sequences encoding the cGMP-binding, cGMP-specific phosphodiesrtrase designated cGB-PDE. Also provided by the invention are methods and materials for the recombinant production of cGB-PDE polypeptide products and methods for identifying compounds which modulate the enzymatic activity of cGB-PDE polypeptides.
CA002141060A 1993-05-27 1994-05-27 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods Expired - Fee Related CA2141060C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2363537A CA2363537C (en) 1993-05-27 1994-05-27 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6805193A 1993-05-27 1993-05-27
US08/068,051 1993-05-27
PCT/US1994/006066 WO1994028144A1 (en) 1993-05-27 1994-05-27 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2363537A Division CA2363537C (en) 1993-05-27 1994-05-27 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods

Publications (2)

Publication Number Publication Date
CA2141060A1 true CA2141060A1 (en) 1994-12-08
CA2141060C CA2141060C (en) 2002-02-19

Family

ID=22080121

Family Applications (3)

Application Number Title Priority Date Filing Date
CA2363537A Expired - Fee Related CA2363537C (en) 1993-05-27 1994-05-27 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
CA002141060A Expired - Fee Related CA2141060C (en) 1993-05-27 1994-05-27 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
CA2698716A Abandoned CA2698716A1 (en) 1993-05-27 1994-05-27 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2363537A Expired - Fee Related CA2363537C (en) 1993-05-27 1994-05-27 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2698716A Abandoned CA2698716A1 (en) 1993-05-27 1994-05-27 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods

Country Status (13)

Country Link
US (7) US5702936A (en)
EP (2) EP0652960B9 (en)
JP (3) JP4150070B2 (en)
AT (2) ATE199569T1 (en)
CA (3) CA2363537C (en)
DE (3) DE69426804T4 (en)
DK (2) DK0652960T3 (en)
ES (2) ES2156898T3 (en)
GR (1) GR3035616T3 (en)
HK (1) HK1013427A1 (en)
LV (1) LV12814B (en)
PT (2) PT652960E (en)
WO (1) WO1994028144A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060222647A1 (en) * 1993-05-27 2006-10-05 Beavo Joseph A Methods and compositions for modulating the activity of PDE5
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
ATE331791T1 (en) * 1998-02-23 2006-07-15 Icos Corp PHOSPHODIESTERASE 10
CA2334942A1 (en) * 1998-07-21 2000-02-03 Takeda Chemical Industries, Ltd. Novel protein and its dna
WO2000033067A1 (en) * 1998-11-25 2000-06-08 Cell Pathways, Inc. Method for diagnosing neoplasia
US6875575B1 (en) 1998-11-25 2005-04-05 Osi Pharmaceuticals, Inc. Diagnostic methods for neoplasia
US6100037A (en) * 1999-01-07 2000-08-08 Incyte Pharmaceuticals, Inc. Human cyclic nucleotide PDEs
US6451807B1 (en) 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
US7098015B2 (en) * 1999-06-11 2006-08-29 Millennium Pharmaceuticals, Inc. 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
US6146876A (en) * 1999-06-11 2000-11-14 Millennium Pharmaceuticals, Inc. 22025, a novel human cyclic nucleotide phosphodiesterase
GB9922125D0 (en) 1999-09-17 1999-11-17 Pfizer Ltd Phosphodiesterase enzymes
CN1297049A (en) * 1999-11-23 2001-05-30 上海博容基因开发有限公司 Polypeptide-human cyclophosphate guanine suppressed phosphodiesterase 17 and polynucleotide for coding said polypeptide
CA2407031A1 (en) 2000-04-19 2001-10-25 Lilly Icos Llc Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
US6794192B2 (en) 2000-06-29 2004-09-21 Pfizer Inc. Target
GB0016009D0 (en) * 2000-06-29 2000-08-23 Pfizer Ltd Target
US6846813B2 (en) * 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
US20030096864A1 (en) * 2000-06-30 2003-05-22 Fang Lawrence Y. Compounds to treat alzheimer's disease
US7179614B2 (en) * 2000-09-14 2007-02-20 Mount Sinai School Of Medicine Screening methods to identify compounds that modulate type I phosphodiesterase (PDE) activity
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
EP1572871A4 (en) * 2001-04-20 2007-11-14 Sinai School Medicine T1r3 a novel taste receptor
US20070213407A1 (en) * 2001-06-29 2007-09-13 Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc Compounds to treat Alzheimer's disease
IL159722A0 (en) * 2001-07-10 2004-06-20 Oligos Etc Inc Pharmaceutical compositions containing oligonucleotides
GB0126417D0 (en) * 2001-11-02 2002-01-02 Pfizer Ltd Crystal structure
US20050202549A1 (en) * 2001-11-02 2005-09-15 Pfizer Inc Crystal structure
US7304128B2 (en) * 2002-06-04 2007-12-04 E.I. Du Pont De Nemours And Company Carbon nanotube binding peptides
MXPA05011769A (en) * 2003-05-01 2006-01-26 Pfizer Crystal of pde5, its crystal structure and its use in drug design.
JP2010004758A (en) * 2008-06-24 2010-01-14 Probex Inc Cyclic gmp detection method
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
KR101550217B1 (en) * 2014-03-26 2015-09-04 전남대학교산학협력단 Recombinant vector for foreign gene expression without biological circuit interference of host cell and uses thereof
JP6885595B2 (en) * 2015-12-04 2021-06-16 国立大学法人 東京大学 Ligand Fluorescence Sensor Protein and Its Use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1290210B (en) * 1962-12-04 1969-03-06 Siemens Ag Device for machine laying and connecting switching wires
US4129349A (en) * 1975-11-10 1978-12-12 Bell Telephone Laboratories, Incorporated Quick-connect breadboarding system
JPH0797015B2 (en) * 1988-10-28 1995-10-18 株式会社ピーエフユー Position correction method of SMD by image processing
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
JPH038400A (en) * 1989-06-06 1991-01-16 Sharp Corp Positional correction of printed substrate
US4958013A (en) * 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
US5015637A (en) * 1990-05-25 1991-05-14 Hoechst-Roussel Pharmaceutical Inc. Pyrido[3,4-b]pyrrolo[1,2-e][1,4,5]oxadiazepines
ES2204891T3 (en) * 1991-04-19 2004-05-01 The Board Of Regents Of The University Of Washington DNA CODIFYING PHOSPHODESTERASES OF MAMMALS.
AU2580892A (en) * 1991-09-05 1993-04-05 Isis Pharmaceuticals, Inc. Determination of oligonucleotides for therapeutics, diagnostics and research reagents
US6403302B1 (en) * 1992-09-17 2002-06-11 California Institute Of Technology Methods and compositions for triple helix formation

Also Published As

Publication number Publication date
CA2363537C (en) 2010-07-06
EP0652960B9 (en) 2004-10-27
DE69426804D1 (en) 2001-04-12
US20030054992A1 (en) 2003-03-20
US5955583A (en) 1999-09-21
CA2141060C (en) 2002-02-19
PT652960E (en) 2001-08-30
US5702936A (en) 1997-12-30
JPH08502900A (en) 1996-04-02
ES2333691T3 (en) 2010-02-26
ATE438723T1 (en) 2009-08-15
PT1038963E (en) 2009-10-13
DE69435227D1 (en) 2009-09-17
ES2156898T3 (en) 2001-08-01
DE69426804T4 (en) 2005-10-13
WO1994028144A1 (en) 1994-12-08
EP1038963B1 (en) 2009-08-05
JP4450767B2 (en) 2010-04-14
CA2363537A1 (en) 1994-12-08
HK1013427A1 (en) 1999-08-27
US6037119A (en) 2000-03-14
DE69426804T2 (en) 2001-07-19
JP2005245467A (en) 2005-09-15
LV12814A (en) 2002-04-20
LV12814B (en) 2002-10-20
EP0652960A1 (en) 1995-05-17
JP4150070B2 (en) 2008-09-17
US20060216809A1 (en) 2006-09-28
US5652131A (en) 1997-07-29
DK0652960T3 (en) 2001-04-17
GR3035616T3 (en) 2001-06-29
ATE199569T1 (en) 2001-03-15
JP2010042035A (en) 2010-02-25
EP0652960B1 (en) 2001-03-07
DK1038963T3 (en) 2009-11-23
CA2698716A1 (en) 1994-12-08
EP1038963A3 (en) 2000-10-04
EP1038963A2 (en) 2000-09-27
US20050196833A1 (en) 2005-09-08

Similar Documents

Publication Publication Date Title
CA2141060A1 (en) Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
CA2085881A1 (en) Dna encoding mammalian phosphodiesterases
CA2177827A1 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
AU591061B2 (en) Process for the manufacture of thrombin inhibitors
DK0684313T3 (en) Phytase activity polypeptides
WO1998056927A3 (en) Nucleic acids encoding polypeptide having protease activity
CA2318030A1 (en) Acpl dna and polypeptides
AU3498189A (en) Fibronectin binding protein
CA2170515A1 (en) Nucleotide sequences for novel protein tyrosine phosphatases
WO1999015666A3 (en) Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof
IL129055A0 (en) Mutant penicillin g acylases
EP1449849A3 (en) Protease-resistant thrombomodulin analog
AU6661490A (en) Novel polypeptides, the DNA sequences allowing their expression, method of preparation, and utilization
NO177570C (en) Process for the preparation of peptides with fibronectin binding properties, microorganism and DNA sequence encoding peptides with fibronectin binding properties
AU4218389A (en) Peptide compounds
EP0759470A3 (en) Gene encoding endoglycoceramidase activator
WO1988009378A3 (en) Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
AU5727099A (en) A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme
CA2163081A1 (en) Thermoresistant Alpha-1-Antitrypsin Mutein
EP0801133A3 (en) Hydroperoxide lyases
WO2000043525A3 (en) Metalloproteinase-disintegrin family members: svph dnas and polypeptides
EP1482049A3 (en) A protein tyrosine kinase.
MX9700940A (en) Macrophage derived chemokine and chemokine analogs.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed